Pay in 4 interest-free payments of $26.25 Learn more
Ships within 48 hours · Estimated delivery Oct 13 - Oct 18
as in the case of chemotherapy
MI-2 is a new tool for better understanding MLL-mediated leukemogenesis and represents a new approach for studying the role of Menin as an oncogenic cofactor of MLL fusion proteins
It did not significantly inhibit tumorsphere formation in the breast cancer cell line SUM159
It is also used to treat several auto-immune diseases including alopecia areata
suggesting that this gene plays an important role in the hepatic fate specification of rMSCs
UPF-648 0532223 as in the case ofUPF 648 is a kynurenine 3 monooxygenase (KMO) inhibitor. UPF 648 binds close to the FAD cofactor and perturbs the local active site structure, preventing productive binding of the substrate l kynurenine. UPF 648 may be potentially useful for neurodegenerative diseases such as Huntington's, Alzheimer's and Parkinson's diseases. Product information CAS Number: 213400 34 1 Molecular Weight: 259. 09 Formula: C11H8Cl2O3 Chemical Name: (1S,2S) 2 (3,4